Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

774 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
Micklethwaite K, Hansen A, Foster A, Snape E, Antonenas V, Sartor M, Shaw P, Bradstock K, Gottlieb D. Micklethwaite K, et al. Among authors: gottlieb d. Biol Blood Marrow Transplant. 2007 Jun;13(6):707-14. doi: 10.1016/j.bbmt.2007.02.004. Epub 2007 Apr 6. Biol Blood Marrow Transplant. 2007. PMID: 17531781 Free article. Clinical Trial.
Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation.
Micklethwaite KP, Clancy L, Sandher U, Hansen AM, Blyth E, Antonenas V, Sartor MM, Bradstock KF, Gottlieb DJ. Micklethwaite KP, et al. Blood. 2008 Nov 15;112(10):3974-81. doi: 10.1182/blood-2008-06-161695. Epub 2008 Sep 3. Blood. 2008. PMID: 18768783 Free article. Clinical Trial.
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K. George B, et al. Among authors: gottlieb d. Transpl Infect Dis. 2010 Aug 1;12(4):322-9. doi: 10.1111/j.1399-3062.2010.00504.x. Epub 2010 May 11. Transpl Infect Dis. 2010. PMID: 20487414
A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group.
George B, Kerridge IH, Gilroy N, Huang G, Hertzberg MS, Bradstock KF, Gottlieb DJ. George B, et al. Among authors: gottlieb dj. Transpl Infect Dis. 2012 Apr;14(2):141-8. doi: 10.1111/j.1399-3062.2011.00706.x. Epub 2012 Jan 29. Transpl Infect Dis. 2012. PMID: 22283838
774 results